C. Stehouwer

First name
C.
Middle name
D. A.
Last name
Stehouwer
Tran-Duy, A., Connell, N. J., Vanmolkot, F. H., Souverein, P. C., de Wit, N. J., Stehouwer, C. D. A., et al. (2018). Use of proton pump inhibitors and risk of iron deficiency: a population-based case-control study. J Intern Med. http://doi.org/10.1111/joim.12826
van Dalem, J., Brouwers, M., Stehouwer, C. D. A., Krings, A., Klungel, O. H., Driessen, J. H. M., et al. (2018). Risk of a first-ever acute myocardial infarction and all-cause mortality with sulphonylurea treatment: A population-based cohort study. Diabetes Obes Metab. http://doi.org/10.1111/dom.13168
Tran-Duy, A., Connell, N. J., Vanmolkot, F. H., Souverein, P. C., de Wit, N. J., Stehouwer, C. D. A., et al. (2019). Use of proton pump inhibitors and risk of iron deficiency: a population-based case-control study. J Intern Med. http://doi.org/10.1111/joim.12826
van Dalem, J., Driessen, J. H. M., Burden, A. M., Stehouwer, C. D. A., Klungel, O. H., de Vries, F., & Brouwers, M. (2021). Thiazolidinediones and Glucagon-like Peptide-1 Receptor Agonists and the Risk of Nonalcoholic Fatty Liver Disease: A Cohort Study. Hepatology. http://doi.org/10.1002/hep.32012